{"comparisonGroups":["Hank's balanced salt solution","doxycycline"],"dateCreated":"2025-09-26 00:00:00","display_title":"Control vs doxycycline treatment","group_a_title":"Control group treated with Hank's balanced salt solution.. Provides baseline for comparison with doxycycline-treated samples.","group_b_title":"Treatment group receiving doxycycline.. Represents the effect of doxycycline treatment on the samples.","id":"MTBLS4709_0001_00000001","pvalueThreshold":0.05,"ratioThresholdLower":"1/1.5","ratioThresholdUpper":1.5,"significantFeatures":3,"studyId":"MTBLS4709","studyUrl":"http://integmet.org/study/MTBLS4709","title":"Hanks_balanced_salt_solution_vs_doxycycline","topHits":[{"chebi_id":"170696","direction":"up","inn_name":"","iupac_name":"[(2R)-2-[(11Z,14Z)-icosa-11,14-dienoyl]oxy-3-pentadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate","metabolite_id":"XSSUJRSOHXBICQ-GPDPEMMZSA-N","pvalue":5.1819352599762525e-05,"ratio":1.7033426812806196,"synonym_name":""},{"chebi_id":"89516","direction":"up","inn_name":"","iupac_name":"","metabolite_id":"LOVKBDFNFACEND-HSEDGGQWSA-N","pvalue":0.0001636280487149,"ratio":1.8008764322091493,"synonym_name":"PC(14:0/22:1)"},{"chebi_id":"75038","direction":"up","inn_name":"","iupac_name":"2-azaniumylethyl (2<i>R</i>)-3-(octadecanoyloxy)-2-[(9<i>Z</i>)-octadec-9-enoyloxy]propyl phosphate","metabolite_id":"JQKOHRZNEOQNJE-DJEJVYNPSA-N","pvalue":0.0397508643642145,"ratio":2.274809650875029,"synonym_name":"2-azaniumylethyl (2<i>R</i>)-2-[(9<i>Z</i>)-octadec-9-enoyloxy]-3-(stearoyloxy)propyl phosphate"}],"totalFeatures":18}